These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 2786360

  • 1. Lysis of human malignant mesothelioma cells by natural killer (NK) and lymphokine-activated killer (LAK) cells.
    Manning LS, Bowman RV, Darby SB, Robinson BW.
    Am Rev Respir Dis; 1989 Jun; 139(6):1369-74. PubMed ID: 2786360
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA, Custer MC, Rosenberg SA, Lotze MT.
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Indomethacin augments lymphokine-activated killer cell generation by patients with malignant mesothelioma.
    Manning LS, Bowman RV, Davis MR, Musk AW, Robinson BW.
    Clin Immunol Immunopathol; 1989 Oct; 53(1):68-77. PubMed ID: 2788546
    [Abstract] [Full Text] [Related]

  • 7. Characteristics and mechanism of IFN-gamma-induced protection of human tumor cells from lysis by lymphokine-activated killer cells.
    de Fries RU, Golub SH.
    J Immunol; 1988 May 15; 140(10):3686-93. PubMed ID: 3129500
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW, Shamim F, Hamon M, Macdonald ID, Prentice HG.
    Exp Hematol; 1995 Dec 15; 23(14):1530-4. PubMed ID: 8542943
    [Abstract] [Full Text] [Related]

  • 10. Capacity of tumor necrosis factor to augment lymphocyte-mediated tumor cell lysis of malignant mesothelioma.
    Bowman RV, Manning LS, Davis MR, Robinson BW.
    Clin Immunol Immunopathol; 1991 Jan 15; 58(1):80-91. PubMed ID: 1983971
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA, Pekle K, Gazzola MV, Collins NH, Bourhis JH, Gillio A.
    J Immunol; 1989 Nov 15; 143(10):3241-9. PubMed ID: 2809200
    [Abstract] [Full Text] [Related]

  • 13. Lymphokine-activated killer (LAK) cell phenomenon. IV. Lysis by LAK cell clones of fresh human tumor cells from autologous and multiple allogeneic tumors.
    Rayner AA, Grimm EA, Lotze MT, Wilson DJ, Rosenberg SA.
    J Natl Cancer Inst; 1985 Jul 15; 75(1):67-75. PubMed ID: 2989604
    [Abstract] [Full Text] [Related]

  • 14. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
    Rosenstein M, Yron I, Kaufmann Y, Rosenberg SA.
    Cancer Res; 1984 May 15; 44(5):1946-53. PubMed ID: 6608989
    [Abstract] [Full Text] [Related]

  • 15. Assessment of human natural killer and lymphokine-activated killer cell cytotoxicity against Toxoplasma gondii trophozoites and brain cysts.
    Dannemann BR, Morris VA, Araujo FG, Remington JS.
    J Immunol; 1989 Oct 15; 143(8):2684-91. PubMed ID: 2477453
    [Abstract] [Full Text] [Related]

  • 16. Ewing's sarcoma: ex vivo sensitivity towards natural and lymphokine-activated killing.
    Atzpodien J, Gulati SC, Shimazaki C, Bührer C, Oz S, Kwon JH, Kolitz JE, Clarkson BD.
    Oncology; 1988 Oct 15; 45(6):437-43. PubMed ID: 3263598
    [Abstract] [Full Text] [Related]

  • 17. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M, Hasegawa H, Nakayabu M, Fukai K, Suzuki S.
    J Clin Lab Immunol; 1993 Oct 15; 40(2):47-60. PubMed ID: 7932628
    [Abstract] [Full Text] [Related]

  • 18. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F, Kajiwara M.
    Oncol Res; 1998 Oct 15; 10(10):483-9. PubMed ID: 10338151
    [Abstract] [Full Text] [Related]

  • 19. Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis.
    Harker WG, Tom C, McGregor JR, Slade L, Samlowski WE.
    Cancer Res; 1990 Sep 15; 50(18):5931-6. PubMed ID: 1975512
    [Abstract] [Full Text] [Related]

  • 20. Lysis of human solid tumor cells by lymphokine-activated natural killer cells.
    Itoh K, Tilden AB, Balch CM.
    J Immunol; 1986 May 15; 136(10):3910-5. PubMed ID: 3084648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.